SFM
PCRX icon

Systematic Financial Management’s Pacira BioSciences PCRX Stock Holding History

Systematic Financial Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,125
Closed -$374K – 392
2020
Q2 		$374K Sell
7,125
-3,000
-30% -$125K 0.02% 186
2020
Q1 		$339K Buy
+10,125
New +$421K 0.02% 277

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Systematic Financial Management's PCRX Position: Q3 2020 in Review

Systematic Financial Management sold out of Pacira BioSciences (PCRX) in Q3 2020, closing a stake of 7,125 shares — an estimated $374K sold.

Systematic Financial Management first reported a position in PCRX in Q1 2020 and held it in 2 quarters. The position peaked at $374K in Q2 2020. 257 funds tracked by Wall St. Rank hold PCRX as of Q3 2020.

  • Systematic Financial Management reported no remaining Pacira BioSciences position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 7,125 Pacira BioSciences shares in Q3 2020, an estimated $374K.
  • Systematic Financial Management first reported a position in Pacira BioSciences in Q1 2020 and held it in 2 quarters.
  • Systematic Financial Management's Pacira BioSciences position peaked at $374K in Q2 2020.
  • 257 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.